Skip to content
value.today

Cellics Therapeutics, Inc.

🇺🇸 San Diego, California, USABiotechnologyFounded 2014
Total raised
$33 M
4 rounds on record
Latest round
$7 M
Feb 2022
First round on record
Feb 2016
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Cellics Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2022$7 MNo. 4$2 to $10 million

Cellics Therapeutics, Inc.: Raise no. 4, Feb 2022

Investors in this round

1 investor had bought by the notice of Feb 17, 2022: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $25 M offered; $18 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jie Zhang · Executive Officer, Director
  • Lili Xie · Executive Officer
  • Angela Fang Chen · Director
  • Cihui Li · Director
  • Liangfang Zhang · Director
  • Wei Shen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jie Zhang, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 17, 2022. Read the notice at the SEC.

equitySEC
May 2020$13 MNo. 3$10 to $50 million

Cellics Therapeutics, Inc.: Raise no. 3, May 2020

Investors in this round

3 investors had bought by the notice of Jun 9, 2020: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $13 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Huiqing Zhu · Executive Officer
  • Lili Xie · Executive Officer, Director
  • Angela Fang Chen · Director
  • Dai Jinming · Director
  • Weiwei Gao · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “$9,999,996.67 was issued in exchange for an in-kind contribution of certain intellectual property assets”

Signed by Huiqing Zhu, Chief Operating Officer. Source: SEC Form D, newest notice filed Jun 9, 2020. Read the notice at the SEC.

equitySEC
Apr 2018$7 MNo. 2$2 to $10 million

Cellics Therapeutics, Inc.: Raise no. 2, Apr 2018

Investors in this round

4 investors had bought by the notice of Apr 23, 2018: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Huiqing Zhu · Executive Officer, Director
  • Lili Xie · Executive Officer, Director
  • Dai Jinming · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Huiqing Zhu, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 23, 2018. Read the notice at the SEC.

equitySEC
Feb 2016$6 MNo. 1$2 to $10 million

Cellics Therapeutics, Inc.: Raise no. 1, Feb 2016

Investors in this round

1 investor had bought by the notice of Apr 21, 2017: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Huiqing Zhu · Executive Officer, Director
  • Lili Xie · Executive Officer, Director
  • Dai Jimming · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Huiqing Zhu, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Apr 21, 2017. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Cellics Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2022).

    SEC Form D · Feb 2022

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Feb 2022

That is all the official record says: Cellics Therapeutics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Cellics Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 4 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Cellics Therapeutics, Inc.
NameRoleNamed in
Jie ZhangExecutive officerFeb 2022
Lili XieExecutive officerFeb 2022
Huiqing ZhuExecutive officerJun 2020
Angela Fang ChenDirectorFeb 2022
Cihui LiDirectorFeb 2022
Jie ZhangDirectorFeb 2022
Liangfang ZhangDirectorFeb 2022
Wei ShenDirectorFeb 2022
Dai JinmingDirectorJun 2020
Lili XieDirectorJun 2020
Weiwei GaoDirectorJun 2020
Huiqing ZhuDirectorApr 2018
Dai JimmingDirectorApr 2017